Limits...
MicroRNA-126 regulates the induction and function of CD4(+) Foxp3(+) regulatory T cells through PI3K/AKT pathway.

Qin A, Wen Z, Zhou Y, Li Y, Li Y, Luo J, Ren T, Xu L - J. Cell. Mol. Med. (2013)

Bottom Line: Further study showed that silencing of miR-126 using miR-126 antisense oligonucleotides (ASO) could significantly reduce the induction of Tregs in vitro.Furthermore, miR-126 silencing could obviously reduce the expression of Foxp3 on Tregs, which was accompanied by decreased expression of CTLA-4 and GITR, as well as IL-10 and TGF-β, and impair its suppressive function.Mechanistic evidence showed that silencing of miR-126 enhanced the expression of its target p85β and subsequently altered the activation of PI3K/Akt pathway, which was ultimately responsible for reduced induction and suppressive function of Tregs.

View Article: PubMed Central - PubMed

Affiliation: Department of Immunology, Zunyi Medical College, Guizhou, 563000, China.

Show MeSH

Related in: MedlinePlus

MiR-126 regulated Foxp3 expression through PI3K-Akt pathway. CD4+ CD25+ T cells (Tregs) purified from splenocytes of normal Balb/c mice by MACS were transiently transfected with miR-126 ASO (10 ng) or Scramble control (10 ng), and then cultured in the presence of anti-CD3/CD28 plus IL-2 (50 IU/ml) for 48 h. The expression of p85β, Akt and mTOR or phosphorylation level of Akt and mTOR were analysed by Western blot (A). (B) CD4+CD25+ T cells were transiently transfected with miR-126 ASO (10 ng) or Scramble control plus p85β RNAi (5 ng) or control RNAi (5 ng). Then, cells were cultured in the presence of anti-CD3/CD28 plus IL-2 (50 IU/ml) for 48 h. The expression of Foxp3 was analysed by FACS. (C) CD4+CD25− T cells purified from normal Balb/c mice by MACS were stimulated with anti-CD3/CD28 antibody in the presence of TGF-β and IL-2 for 24 h, and then were transiently transfected with miR-126 ASO (10 ng) or scramble control (10 ng) plus p85β RNAi (5 ng) or control RNAi (5 ng). After 4 days, the proportion of Foxp3+ in CD4+ T cells was analysed by FACS and calculated. (D) CD4+CD25+ T cells were transiently transfected with miR-126 ASO (10 ng) or Scramble control. Then, cells were cultured with anti-CD3/CD28 plus IL-2 in the presence of Akt inhibitor IV (1 μM) for 48 h. The expression of Foxp3 was analysed by FACS. (E) CD4+CD25− T cells purified from normal Balb/c mice by MACS were stimulated with anti-CD3/CD28 antibody in the presence of TGF-β and IL-2 for 24 h, and then were transiently transfected with miR-126 ASO (10 ng) or scramble control (10 ng). These cells were cultured in the presence of Akt inhibitor IV (1 μM) for 4 days, the proportion of Foxp3+ in CD4+ T cells was analysed by FACS and calculated. One representative of three independent experiments was shown. *P < 0.05.
© Copyright Policy - open-access
Related In: Results  -  Collection

License
getmorefigures.php?uid=PMC3822588&req=5

fig05: MiR-126 regulated Foxp3 expression through PI3K-Akt pathway. CD4+ CD25+ T cells (Tregs) purified from splenocytes of normal Balb/c mice by MACS were transiently transfected with miR-126 ASO (10 ng) or Scramble control (10 ng), and then cultured in the presence of anti-CD3/CD28 plus IL-2 (50 IU/ml) for 48 h. The expression of p85β, Akt and mTOR or phosphorylation level of Akt and mTOR were analysed by Western blot (A). (B) CD4+CD25+ T cells were transiently transfected with miR-126 ASO (10 ng) or Scramble control plus p85β RNAi (5 ng) or control RNAi (5 ng). Then, cells were cultured in the presence of anti-CD3/CD28 plus IL-2 (50 IU/ml) for 48 h. The expression of Foxp3 was analysed by FACS. (C) CD4+CD25− T cells purified from normal Balb/c mice by MACS were stimulated with anti-CD3/CD28 antibody in the presence of TGF-β and IL-2 for 24 h, and then were transiently transfected with miR-126 ASO (10 ng) or scramble control (10 ng) plus p85β RNAi (5 ng) or control RNAi (5 ng). After 4 days, the proportion of Foxp3+ in CD4+ T cells was analysed by FACS and calculated. (D) CD4+CD25+ T cells were transiently transfected with miR-126 ASO (10 ng) or Scramble control. Then, cells were cultured with anti-CD3/CD28 plus IL-2 in the presence of Akt inhibitor IV (1 μM) for 48 h. The expression of Foxp3 was analysed by FACS. (E) CD4+CD25− T cells purified from normal Balb/c mice by MACS were stimulated with anti-CD3/CD28 antibody in the presence of TGF-β and IL-2 for 24 h, and then were transiently transfected with miR-126 ASO (10 ng) or scramble control (10 ng). These cells were cultured in the presence of Akt inhibitor IV (1 μM) for 4 days, the proportion of Foxp3+ in CD4+ T cells was analysed by FACS and calculated. One representative of three independent experiments was shown. *P < 0.05.

Mentions: Recent evidence showed that PI3K/Akt pathway was critical for the expression of Foxp3 in Tregs [10, 11]. And other research works reported miR-126 could target to p85β and regulate the transduction of PI3K/Akt pathway [17, 18]. Then, the direct effect of miR-126 mimics on the expression of p85β in Tregs was detected and similar result was found that miR-126 mimics could obviously inhibit p85 expression in Tregs (data not shown). Next, we further investigated whether miR-126 silencing could enhance the expression of p85β and successively regulate the transduction of TCR-mediated PI3K/Akt pathway which ultimately influenced the expression of Foxp3 in Tregs. As shown in Figure 5A, the expression of p85β in miR-126 ASO-transfected group increased about 2.5 times (P < 0.05). Moreover, the level of phosphorylation of Akt and phosphorylation of mTOR increased significantly in miR-126 ASO-transfected group compared with those in control group (Fig. 5A), indicating that miR-126 could regulate the activation of PI3K/Akt pathway in Tregs. Consistently, we also found that miR-126 ASO significantly enhance the expression of p85β, as well as phosphorylated Akt and phosphorylated mTOR, in the induction of Tregs (Supporting Information Figure S2, P < 0.05). To further confirm whether this enhanced activation of PI3K-Akt pathway was responsible for reduced expression of Foxp3 in Tregs, we further cotransfected p85β RNAi into Tregs and found that p85β RNAi could abrogate the effect of miR-126 ASO on the expression of Foxp3 in Tregs (Fig. 5B, P < 0.05). Furthermore, p85β RNAi also could reverse the effect of miR-126 ASO on Tregs induction (Fig. 5C, P < 0.05). To investigate the efficiency and specificity of p85β RNAi on Tregs in miR-126 ASO-transfected group, we further detected the expression of total p85, p85α and p85β on Tregs in miR-126 ASO-transfected group. Our data showed that p85β RNAi could significantly reduce the expression of p85β in miR-126 ASO-transfected Tregs (Supporting Information Figure S3A and B, P < 0.05). However, p85β RNAi did not alter the expression of p85α in miR-126 ASO-transfected Tregs (Supporting Information Figure S3B, P > 0.05). Finally, to confirm this finding, Akt inhibitor IV also was used and similar results were obtained (Fig. 5D and E, P < 0.05). These data strongly suggested that silencing of miR-126 reduced the expression of Foxp3 through up-regulating PI3K/Akt pathway, which ultimately altered the induction and suppressive function of Tregs.


MicroRNA-126 regulates the induction and function of CD4(+) Foxp3(+) regulatory T cells through PI3K/AKT pathway.

Qin A, Wen Z, Zhou Y, Li Y, Li Y, Luo J, Ren T, Xu L - J. Cell. Mol. Med. (2013)

MiR-126 regulated Foxp3 expression through PI3K-Akt pathway. CD4+ CD25+ T cells (Tregs) purified from splenocytes of normal Balb/c mice by MACS were transiently transfected with miR-126 ASO (10 ng) or Scramble control (10 ng), and then cultured in the presence of anti-CD3/CD28 plus IL-2 (50 IU/ml) for 48 h. The expression of p85β, Akt and mTOR or phosphorylation level of Akt and mTOR were analysed by Western blot (A). (B) CD4+CD25+ T cells were transiently transfected with miR-126 ASO (10 ng) or Scramble control plus p85β RNAi (5 ng) or control RNAi (5 ng). Then, cells were cultured in the presence of anti-CD3/CD28 plus IL-2 (50 IU/ml) for 48 h. The expression of Foxp3 was analysed by FACS. (C) CD4+CD25− T cells purified from normal Balb/c mice by MACS were stimulated with anti-CD3/CD28 antibody in the presence of TGF-β and IL-2 for 24 h, and then were transiently transfected with miR-126 ASO (10 ng) or scramble control (10 ng) plus p85β RNAi (5 ng) or control RNAi (5 ng). After 4 days, the proportion of Foxp3+ in CD4+ T cells was analysed by FACS and calculated. (D) CD4+CD25+ T cells were transiently transfected with miR-126 ASO (10 ng) or Scramble control. Then, cells were cultured with anti-CD3/CD28 plus IL-2 in the presence of Akt inhibitor IV (1 μM) for 48 h. The expression of Foxp3 was analysed by FACS. (E) CD4+CD25− T cells purified from normal Balb/c mice by MACS were stimulated with anti-CD3/CD28 antibody in the presence of TGF-β and IL-2 for 24 h, and then were transiently transfected with miR-126 ASO (10 ng) or scramble control (10 ng). These cells were cultured in the presence of Akt inhibitor IV (1 μM) for 4 days, the proportion of Foxp3+ in CD4+ T cells was analysed by FACS and calculated. One representative of three independent experiments was shown. *P < 0.05.
© Copyright Policy - open-access
Related In: Results  -  Collection

License
Show All Figures
getmorefigures.php?uid=PMC3822588&req=5

fig05: MiR-126 regulated Foxp3 expression through PI3K-Akt pathway. CD4+ CD25+ T cells (Tregs) purified from splenocytes of normal Balb/c mice by MACS were transiently transfected with miR-126 ASO (10 ng) or Scramble control (10 ng), and then cultured in the presence of anti-CD3/CD28 plus IL-2 (50 IU/ml) for 48 h. The expression of p85β, Akt and mTOR or phosphorylation level of Akt and mTOR were analysed by Western blot (A). (B) CD4+CD25+ T cells were transiently transfected with miR-126 ASO (10 ng) or Scramble control plus p85β RNAi (5 ng) or control RNAi (5 ng). Then, cells were cultured in the presence of anti-CD3/CD28 plus IL-2 (50 IU/ml) for 48 h. The expression of Foxp3 was analysed by FACS. (C) CD4+CD25− T cells purified from normal Balb/c mice by MACS were stimulated with anti-CD3/CD28 antibody in the presence of TGF-β and IL-2 for 24 h, and then were transiently transfected with miR-126 ASO (10 ng) or scramble control (10 ng) plus p85β RNAi (5 ng) or control RNAi (5 ng). After 4 days, the proportion of Foxp3+ in CD4+ T cells was analysed by FACS and calculated. (D) CD4+CD25+ T cells were transiently transfected with miR-126 ASO (10 ng) or Scramble control. Then, cells were cultured with anti-CD3/CD28 plus IL-2 in the presence of Akt inhibitor IV (1 μM) for 48 h. The expression of Foxp3 was analysed by FACS. (E) CD4+CD25− T cells purified from normal Balb/c mice by MACS were stimulated with anti-CD3/CD28 antibody in the presence of TGF-β and IL-2 for 24 h, and then were transiently transfected with miR-126 ASO (10 ng) or scramble control (10 ng). These cells were cultured in the presence of Akt inhibitor IV (1 μM) for 4 days, the proportion of Foxp3+ in CD4+ T cells was analysed by FACS and calculated. One representative of three independent experiments was shown. *P < 0.05.
Mentions: Recent evidence showed that PI3K/Akt pathway was critical for the expression of Foxp3 in Tregs [10, 11]. And other research works reported miR-126 could target to p85β and regulate the transduction of PI3K/Akt pathway [17, 18]. Then, the direct effect of miR-126 mimics on the expression of p85β in Tregs was detected and similar result was found that miR-126 mimics could obviously inhibit p85 expression in Tregs (data not shown). Next, we further investigated whether miR-126 silencing could enhance the expression of p85β and successively regulate the transduction of TCR-mediated PI3K/Akt pathway which ultimately influenced the expression of Foxp3 in Tregs. As shown in Figure 5A, the expression of p85β in miR-126 ASO-transfected group increased about 2.5 times (P < 0.05). Moreover, the level of phosphorylation of Akt and phosphorylation of mTOR increased significantly in miR-126 ASO-transfected group compared with those in control group (Fig. 5A), indicating that miR-126 could regulate the activation of PI3K/Akt pathway in Tregs. Consistently, we also found that miR-126 ASO significantly enhance the expression of p85β, as well as phosphorylated Akt and phosphorylated mTOR, in the induction of Tregs (Supporting Information Figure S2, P < 0.05). To further confirm whether this enhanced activation of PI3K-Akt pathway was responsible for reduced expression of Foxp3 in Tregs, we further cotransfected p85β RNAi into Tregs and found that p85β RNAi could abrogate the effect of miR-126 ASO on the expression of Foxp3 in Tregs (Fig. 5B, P < 0.05). Furthermore, p85β RNAi also could reverse the effect of miR-126 ASO on Tregs induction (Fig. 5C, P < 0.05). To investigate the efficiency and specificity of p85β RNAi on Tregs in miR-126 ASO-transfected group, we further detected the expression of total p85, p85α and p85β on Tregs in miR-126 ASO-transfected group. Our data showed that p85β RNAi could significantly reduce the expression of p85β in miR-126 ASO-transfected Tregs (Supporting Information Figure S3A and B, P < 0.05). However, p85β RNAi did not alter the expression of p85α in miR-126 ASO-transfected Tregs (Supporting Information Figure S3B, P > 0.05). Finally, to confirm this finding, Akt inhibitor IV also was used and similar results were obtained (Fig. 5D and E, P < 0.05). These data strongly suggested that silencing of miR-126 reduced the expression of Foxp3 through up-regulating PI3K/Akt pathway, which ultimately altered the induction and suppressive function of Tregs.

Bottom Line: Further study showed that silencing of miR-126 using miR-126 antisense oligonucleotides (ASO) could significantly reduce the induction of Tregs in vitro.Furthermore, miR-126 silencing could obviously reduce the expression of Foxp3 on Tregs, which was accompanied by decreased expression of CTLA-4 and GITR, as well as IL-10 and TGF-β, and impair its suppressive function.Mechanistic evidence showed that silencing of miR-126 enhanced the expression of its target p85β and subsequently altered the activation of PI3K/Akt pathway, which was ultimately responsible for reduced induction and suppressive function of Tregs.

View Article: PubMed Central - PubMed

Affiliation: Department of Immunology, Zunyi Medical College, Guizhou, 563000, China.

Show MeSH
Related in: MedlinePlus